ArticleNature communications2022

Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance.

Dhivya Sridaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.